Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
New Molecule Could Slow The Progression Of Parkinson’s
University of Bath researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
Study Could Pave the Way for Painkillers with Fewer Side Effects
Research at SLAC explores promising alternative to morphine.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Possible Neuron Killing Mechanism Behind Alzheimer’s and Parkinson’s Diseases Discovered
$1.4 million grant will enable team to follow up with search for drug candidates.
MAGE Genes Provide Insight into Optimizing Chemotherapy
UT Southwestern Medical Center scientists have identified a new biomarker that could help identify patients who are more likely to respond to certain chemotherapies.
New Screening Tool Could Speed Development Of Ovarian Cancer Drugs
Researchers have built a 3D cell culture system which can help identify small molecules that could be used to treat ovarian cancer.
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Artificially-intelligent Robot Scientist ‘Eve’ Could Boost Search for New Drugs
Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface.
New Metabolic Biomarkers Predict Future Cardiovascular Diseases
Scientists of the Helmholtz Zentrum München contributed to the analysis of the biomarkers.
New Cancer-Fighting Strategy Would Harden Cells to Prevent Metastasis
Potential drug for pancreatic cancer now being tested in animals.

Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.

iASPP, a Potential Drug Target in Cancer Therapy
Sebastien Gillotin, Professor, Oxford University, speaking at Screening Europe 2010

Direct Cellular Patterning and Analysis Using a Novel Microprinting Technology
Nathaniel C. Cady, Assistant Professor of Nanobioscience, College of Nanoscale Science & Engineering, speaking at Single Analysis Summit 2010.

Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.

From Target Focused to High Content Screening in Nutraceutical Discovery
Ann Fowler, Senior Scientist, DSM Nutritional Products, speaking at Screening Europe

Primary, iPS and Stem Cells: Emerging Tools for HTS?
Richard Elgen, President, Bio-discovery, PerkinElmer, speaking at Screening Europe 2010

High-throughput Screening in Human Embryonic Stem Cells for Drug Discovery
Sabrina C. Desbordes, Senior Postdoctoral Fellow, PRBB-Center for Genomic Regulation (CRG), speaking at Screening Europe 2010

Development of an AlphaScreen Assay for Epigenetic Peptide-Protein Interactions: A Target-Family Approach to the Discovery of MBT Antagonists
Tim Wigle, Researcher, University of North Carolina, speaking at Probe Discovery 2009

T-Cell Monitoring of Clinical Samples – Precise and Robust Assays based on DNA Methylation Markers
Ulrich Hoffmueller, Chief Business Officer, Epiontis GmbH, speaking at European Biomarkers Summit 2009

<< 10 11 12 13 14 15 16 >>
Showing Results 121 - 130 of 261
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters